Quest Diagnostics Incorporated (DGX) News

Quest Diagnostics Incorporated (DGX)

Today's Latest Price: $115.35 USD

1.30 (1.14%)

Updated Jul 2 11:13am

Add DGX to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 58 in Medical - Diagnostics/Research

See all "A" rated Strong Buy stocks

Filter DGX News Items

DGX News Results

Event/TimeSymbolCompanyNews DetailStartEndChangePOWR Rating
Loading, please wait...

Latest DGX News From Around the Web

Below are the latest news stories about Quest Diagnostics Inc that investors may wish to consider to help them evaluate DGX as an investment opportunity.

Quest, LabCorp warn of coronavirus testing delays as demand surges amid outbreaks

Quest Diagnostics and LabCorp said there will be delays in coronavirus testing results as demand surges with outbreaks.

ABC News | July 1, 2020

Masimo's New Solution to Reduce Opioid Withdrawal Symptoms

Masimo's (MASI) new solution can help reduce symptoms associated with opioid withdrawal, thereby helping OUD patients with their treatment.

Yahoo | July 1, 2020

Bio-Rad Rides on PCR Test Kits for Coronavirus Amid Cost Woe

The uptick in Bio-Rad's (BIO) core PCR and Droplet Digital PCR product revenues is the result of robust demand due to coronavirus testing and related research.

Yahoo | June 30, 2020

Insurer Humana teams up with Walmart, Quest, LabCorp for COVID-19 testing

U.S. health insurer Humana Inc will offer its members at-home COVID-19 test collection kits, as well as provide access to drive-through testings at the hundreds of neighborhood markets of Walmart Inc, it said on Tuesday. For drive-through testing, the insurer said it has tied up with the retail chain and Quest Diagnostics. Humana said new testing sites at Walmart pharmacies will be added between now and August for pharmacist-observed testing.

Yahoo | June 30, 2020

Luminex Expands COVID-19 Testing With New Antibody Test

Luminex (LMNX) submits an EUA request to the FDA for its first multi-antigen IgG assay.

Yahoo | June 30, 2020

Quest Diagnostics Marks 10 Years of Commitment to Reducing Employee Cancer Risk as CEO Cancer Gold Standard™ Employer

Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, marks its 10-year anniversary as a CEO Cancer Gold Standard™ employer this year, signifying its commitment to implementing employee health strategies that will reduce cancer risk among its workforce.

Yahoo | June 30, 2020

Myriad Genetics' myPath Melanoma Proved Superior Per New Study

Myriad Genetics' (MYGN) myPath Melanoma's accuracy to classify skin lesions, termed as indeterminate by standard pathological review, validated by the latest study.

Yahoo | June 29, 2020

Here's Why You Should Hold on to Illumina Stock for Now

Investors continue to be optimistic about Illumina (ILMN) backed by its focus on partnerships and robust demand for its products.

Yahoo | June 29, 2020

CEO Roundtable on Cancer Celebrates Employers marking Ten-Year CEO Cancer Gold Standard™ Anniversary

The CEO Cancer Gold Standard™, the employer-led health and wellness accreditation program of the CEO Roundtable on Cancer, is now helping more than seven million employees and their family members prevent and address cancer through workplace-based programming. This year, 18 Gold Standard employers mark their ten-year anniversary as Gold Standard employers, having maintained a strong commitment to the health of their employees and satisfying the latest, comprehensive requirements of the Gold Standard.

Yahoo | June 29, 2020

Ooma, Chico's, Ericsson, Quest and Kroger as Zacks Bull and Bear of the Day

Ooma, Chico???s, Ericsson, Quest and Kroger as Zacks Bull and Bear of the Day

Yahoo | June 25, 2020

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.7368 seconds.